Hexadox Pharmaceuticals Private Limited
About Hexadox Pharmaceuticals Private Limited
Data last updated:
Hexadox Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 12 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2020PTC137152. Its GSTIN is 29AAFCH3806H1ZK (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Lokesh Bangady Killur Rao and Belliappa Devaiah Alamengada.
Its last annual general meeting (AGM) was held on 05 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.18 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹10.11 Lakh (net margin 2.4%) and EBITDA of ₹19.12 Lakh (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years.
The company has about 15 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹14.06 Lakh on record. The company has 1 deal on record (1 secondary share transfer); the latest was in September 2020. Its 10 peer companies in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Labqom-Sewa Private Limited with revenue of ₹4.19 Cr.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.63 Ragas Skin 2nd Floor, Opp. Kadirenahalli Petrol Bunk Subramanyapura Main Road, Bangalore, Karnataka, India – 560061
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Hexadox Pharmaceuticals Private Limited
The main business activity of Hexadox Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Hexadox Pharmaceuticals Private Limited FY 2025 filings available
Hexadox Pharmaceuticals Private Limited reported revenue of ₹4.18 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Hexadox Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 34% over three years, including 23% growth in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Hexadox Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹19.12 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.11 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Hexadox Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hexadox Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Hexadox Pharmaceuticals Private Limited
Hexadox Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Labqom-Sewa Private Limited | ₹4.19 Cr (FY 2025) | •••• | •••• | -43.0% | •••• | Gandhinagar, Gujarat, India |
| Osakatek India Private Limited | ₹4.19 Cr (FY 2024) | •••• | •••• | -32.0% | •••• | New Delhi, Delhi, India |
| Morsef Pharmaceuticals Private Limited | ₹4.18 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Mediart Healthcare Private Limited | ₹4.18 Cr (FY 2025) | •••• | •••• | -38.0% | •••• | Nashik, Maharashtra, India |
| Fab Pharmaceuticals Private Limited | ₹4.18 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Bangalore, Karnataka, India |
| Hexadox Pharmaceuticals Private Limited this company | ₹4.18 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Bangalore, Karnataka, India |
| Zaneka Pharmaceuticals Private Limited | ₹4.17 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Haridwar, Uttarakhand, India |
| Seno Biotech Private Limited | ₹4.17 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Barmer, Rajasthan, India |
| Sradya Lifecare Private Limited | ₹4.16 Cr (FY 2024) | •••• | •••• | 76.0% | •••• | Haryana, India |
| Cura Healthcare Private Limited | ₹4.16 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Chennai, Tamil Nadu, India |
| Mandore Pharma Private Limited | ₹4.16 Cr (FY 2025) | •••• | •••• | 140.0% | •••• | Shamli, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Hexadox Pharmaceuticals by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Hexadox Pharmaceuticals Private Limited
Hexadox Pharmaceuticals has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lokesh Bangady Killur Rao | Director | 25 Sep 2020 | 6 Years 0 Months | Current |
| Belliappa Devaiah Alamengada | Director | 25 Sep 2020 | 6 Years 0 Months | Current |
| Sudheendra Ghalacharya Udbalker Also directs: Krian Healthcare Private Limited | Director | 12 Aug 2020 | 6 Years 2 Months | Current |
| Ravindra Babu Puligundla | Director | 12 Aug 2020 | 6 Years 2 Months | Current |
| Venkatapathibhatta Rajkumar | Director | 12 Aug 2020 | 6 Years 2 Months | Current |
| Manojkumar Hiralal Parekh | Director | 12 Aug 2020 | 6 Years 2 Months | Current |
Ownership and Shareholding of Hexadox Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hexadox Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2023 | Hdfc Bank Limited | ₹14.06 Lakh | Open |
Total charge records: 1 View all charges
Deals & Funding of Hexadox Pharmaceuticals Private Limited
Hexadox Pharmaceuticals Private Limited has 1 deal on record (1 secondary share transfer); the latest was in September 2020.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Hexadox Pharmaceuticals Private Limited
Hexadox Pharmaceuticals Private Limited has a workforce of 15 employees as of Apr 03, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hexadox Pharmaceuticals Private Limited
Hexadox Pharmaceuticals Private Limited has 8 board changes on record since 2020: 6 appointments and 2 cessations. The latest: Belliappa Devaiah Alamengada ceased to be Additional Director on 23 Jul 2021.
Credit Ratings, Litigation & Regulatory Alerts for Hexadox Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hexadox Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hexadox Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hexadox Pharmaceuticals Private Limited
Hexadox Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCH3806H1ZK | Karnataka | Active | 20 Sep 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hexadox Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hexadox Pharmaceuticals Private Limited
Hexadox Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 12 August 2020 (6+ years old) and is registered under CIN U24290KA2020PTC137152.
Hexadox Pharmaceuticals reported revenue of ₹4.18 Cr for FY 2025 (up 23% YoY).
Hexadox Pharmaceuticals has 6 current directors:
- Lokesh Bangady Killur Rao - Director
- Belliappa Devaiah Alamengada - Director
- Sudheendra Ghalacharya Udbalker - Director
- Ravindra Babu Puligundla - Director
- Venkatapathibhatta Rajkumar - Director
- Manojkumar Hiralal Parekh - Director
Hexadox Pharmaceuticals reported a net profit of ₹10.11 Lakh (net margin 2.4%) and EBITDA of ₹19.12 Lakh (EBITDA margin 4.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Hexadox Pharmaceuticals is 34% over three years. In the latest year (FY 2025) revenue rose 23%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Hexadox Pharmaceuticals is 29AAFCH3806H1ZK, registered in Karnataka.
The CIN (Corporate Identification Number) of Hexadox Pharmaceuticals is U24290KA2020PTC137152. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hexadox Pharmaceuticals was incorporated on 12 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
Hexadox Pharmaceuticals has 1 deal on record (1 secondary share transfer); the latest was in September 2020.
The peers of Hexadox Pharmaceuticals by revenue are Labqom-Sewa Private Limited, Osakatek India Private Limited, Morsef Pharmaceuticals Private Limited, Mediart Healthcare Private Limited, Fab Pharmaceuticals Private Limited and 5 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals).
Belliappa Devaiah Alamengada ceased to be Additional Director on 23 Jul 2021. Lokesh Bangady Killur Rao ceased to be Additional Director on 23 Jul 2021. Belliappa Devaiah Alamengada was appointed as Director on 25 Sep 2020. Hexadox Pharmaceuticals has 8 board changes on record in total.